Vera Therapeutics, Inc. (VERA) Misses Q2 EPS by 6c
Tweet
Share
E-mailGet Alerts VERA Hot Sheet
Price: $34.23 +0.44%
EPS Growth %: -27.8%
Financial Fact:
Service revenues: 3.57M
Today's EPS Names:
PMCB, PLCE, DOMO, More
EPS Growth %: -27.8%
Financial Fact:
Service revenues: 3.57M
Today's EPS Names:
PMCB, PLCE, DOMO, More
Join SI Premium – FREE
Vera Therapeutics, Inc. (NASDAQ: VERA) reported Q2 EPS of ($0.62), $0.06 worse than the analyst estimate of ($0.56).
For earnings history and earnings-related data on Vera Therapeutics, Inc. (VERA) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Pizza Hut CEO Aaron Powell resigns
- Credo Technology Group Holding (CRDO) Tops Q1 EPS by 4c; offers guidance
- Lodestar Metals signs $75,000 investor relations deal with NIA
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
